SMYD2 and cervical carcinoma: Bioinformatic method were performed to analyze the expression of SMYD2 at mRNA levels in cervical cancer patients by using GEPIA, an online analytical database that analyze cases from TCGA, and we found that SMYD2 was abnormal highly expressed in the cervical cancer tissues compared with normal tissues (Fig. 1a, P < 0.05, http://gepia.cancer-pku.cn/detail.php?gene=SMYD2).